Abstract
Sickle cell disease patients are commonly treated at transfusion medicine services, and understanding of the hepatic manifestations of the disease is key for optimal management, specifically, in individuals presenting with sickle cell intrahepatic cholestasis (SCIC). SCIC represents a rare, severe hepatic crisis wherein sinusoidal red cell sickling leads to massive hepatocyte dysfunction and cholestatic laboratory findings. Acute SCIC is defined by abdominal pain with progressive hepatic injury associated with hyperbilirubinemia, renal failure, encephalopathy, and coagulopathy. Patients are generally managed with red blood cell exchange transfusion (RBCEx), when available, as this is a potentially fatal condition. Simple transfusion may be utilized in resource-poor environment or when patients refuse RBCEx. As less than 50 adult cases have been described in the literature, many of them with limited follow-up, randomized clinical trials comparing RBCEx with other treatments are currently unfeasible. Likewise, a chronic form exists, but is less well characterized, and is associated with persistent bilirubinemia and a variable course in terms of progressive hepatic disease. We undertake a brief review of the literature and discuss two cases of SCIC managed with RBCEx at our institution.
Article PDF
Avoid common mistakes on your manuscript.
References
Hosoya, H, Levine, J, Abt, P, Henry, D, Porter, DL, Gill, S. Toward dual hematopoietic stem-cell transplantation and solid-organ transplantation for sickle-cell disease. Blood Adv 2018;2; 575–85.
Hassell, KL. Population estimates of sickle cell disease in the US. Am J Prev Med 2010;38;S512–S21.
Lanzkron, S, Carroll, CP, Haywood, C. The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database. Am J Hematol 2010;85;797–9.
Manci, EA, Culberson, DE, Yang, Y. Causes of death in sickle cell disease: an autopsy study. Br J Haematol 2003;123;359–65.
Gardner, K, Suddle, A, Kane, P, O’Grady, J, Heaton, N, Bomford, A, Thein, SL. How we treat sickle hepatopathy and liver transplantation in adults. Blood 2014;123;2302–7.
Chou, ST, Fasano, RM. Management of patients with sickle cell disease using transfusion therapy: guidelines and complications. Hematol Oncol Clin N Am 2016;30;591–608.
Banerjee, S, Owen, C, Chopra, S. Sickle cell hepatopathy. Hepatology 2001;33;1021–8.
Sheehy, TW. Sickle cell hepatopathy. South Med J 1977;70;533–7.
Issa, H, Al-Salem, AH. Hepatobiliary manifestations of sickle cell anemia. Gastroenterol Res 2010;3;1–8.
Gilli, SCO, Boin, IFS, Sergio Leonardi, L, Luzo, ACM, Costa, FF, Saad, STO. Liver transplantation in a patient with S(beta)o-thalassemia. Transplantation 2002;74;896–8.
Altintas, E, Tiftik, EN, Ucbilek, E, Sezgin, O. Sickle cell anemia connected with chronic intrahepatic cholestasis: a case report. Turk J Gastroenterol 2003;14;215–18.
Vlachaki, E, Andreadis, P, Neokleous, N, Agapidou, A, Vetsiou, E, Katsinelos, P, Boura, P. Successful outcome of chronic intrahepatic cholestasis in an adult patient with sickle cell/𝛽. Case Rep Hematol 2014;2014;3–6.
D’Ambrosio, R, Maggioni, M, Donato, MF, Lampertico, P, Cappellini, MD, Graziadei, G. Decompensated cirrhosis and sickle cell disease: case reports and review of the literature. Hemoglobin 2017;41;131–3.
Maher, MM, Mansour, AH. Study of chronic hepatopathy in patients with sickle cell disease. Gastroenterol Res 2009;2;338–43.
Grover, V. Clinical manifestations of sickle-cell anaemia. Ann Intern Med J 1947;26;843–51.
Green, TW, Conley, CL, Berthrong, M. The liver in sickle cell anemia. Johns Hopkins Med J 1953;92;99–127.
Wade, FA. Sickle cell crisis resembling obstructive (cholangiolar type) jaundice. Report of a case and review of the literature. Va Med Mon 1960;87;474–8.
Sheehy, TW, Law, DE, Wade, BH. Exchange transfusion for sickle cell intrahepatic cholestasis. Arch Intern Med 1980;140;1364–6.
Ahn, H, Li, CS, Wang, W. Sickle cell hepatopathy: clinical presentation, treatment, and outcome in pediatric and adult patients. Pediatr Blood Cancer 2005;45;184–90.
Chaturvedi, S, Debaun, MR. Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: the last 40 years. Am J Hematol 2016;91;5–14.
Betrosian, A, Balla, M, Kafiri, G, Palamarou, C, Sevastos, N. Reversal of liver failure in sickle cell vaso-occlusive crisis. Am J Med Sci 1996;311;292–5.
Hosiriluck, N, Rassameehiran, S, Argueta, E, Tijani, L. Reversal of liver function without exchange transfusion in sickle cell intrahepatic cholestasis. Proc (Bayl Univ Med Cent) 2014;27; 361–3.
Martí-Carvajal, AJ, Simancas-Racines, D. Interventions for treating intrahepatic cholestasis in people with sickle cell disease. Cochrane Database Syst Rev 2015;1;CD010985.
Martí-Carvajal, AJ, Martí-Amarista, CE. Interventions for treating intrahepatic cholestasis in people with sickle cell disease. Cochrane Database Syst Rev 2017;7;CD010985.
Schwartz, A, Padmanabhan, A, Aqui, N, Balogun, RA, Connelly-Smith, L, Delaney, M, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the seventh special issue. J Clin Apher 2016;31; 149–62.
Baichi, MM, Arifuddin, RM, Mantry, PS, Bozorgzadeh, A, Ryan, C. Liver transplantation in sickle cell anemia: a case of acute sickle cell intrahepatic cholestasis and a case of sclerosing cholangitis. Transplantation 2005;80;1630–2.
Costa, DB, Miksad, R, Buff, MS, Wang, Y, Dezube, BJ. Case of fatal sickle cell intrahepatic cholestasis despite use of exchange transfusion in an African-American patient. J Natl Med Assoc 2006;98; 1183–7.
Guimarães de, JA, Silva dos, S. Sickle cell intrahepatic cholestasis unresponsive to exchange blood transfusion: a case report. Rev Bras Hematol Hemoter 2017;39;163–6.
Zakaria, N, Knisely, A, Portmann, B, Mieli-Vergani, G, Wendon, J, Arya, R, Devlin, J. Acute sickle cell hepatopathy represents a potential contraindication for percutaneous liver biopsy. Blood 2003;101;101–3.
Fort, R. Recommendations for the use of red blood cell exchange in sickle cell disease. Transfus Apher Sci 2019;58;128–31.
Kwun Lui, S, Krasinskas, A, Shah, R, Tracht, JM. Orthotropic liver transplantation for acute intrahepatic cholestasis in sickle cell disease: clinical and histopathologic features of a rare case. Int J Surg Pathol 2019;27;411–17.
Shah, R, Taborda, C, Chawla, S. Acute and chronic hepatobiliary manifestations of sickle cell disease: a review. World J Gastrointest Pathophysiol 2017;8;108.
Kassim, AA, Sharma, D. Hematopoietic stem cell transplantation for sickle cell disease: the changing landscape. Hematol Oncol Stem Cell Ther 2017;10;259–66.
Cappelli, B, Volt, F, Tozatto-Maio, K, Scigliuolo, G, Ferster, A, Dupont, S, et al. Risk factors and outcomes according to age at transplantation with an hla-identical sibling for sickle cell disease. Haematologica 2019;104.
Bernaudin, F, Verlhac, S, Peffault de Latour, R, Dalle, JH, Brousse, V, Petras, E, et al. Association of matched sibling donor hematopoietic stem cell transplantation with transcranial doppler velocities in children with sickle cell anemia. JAMA 2019; 321;266–76.
Foell, J, Schulte, JH, Pfirstinger, B, Troeger, A, Wolff, D, Edinger, M, et al. Haploidentical CD3 or 𝛼/𝛽 T-cell depleted HSCT in advanced stage sickle cell disease. Bone Marrow Transplant 2019.
Coppell, JA, Richardson, PG, Soiffer, R, Martin, PL, Kernan, NA, Chen, A, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant 2010;16;157–68.
Im, DD, Essien, U, DePasse, JW, Chiappa, V. Acute on chronic liver failure in a patient with sickle cell anaemia (HbSS). BMJ Case Rep. 2015;1–5.
Morrow, JD, McKenzie, SW. Survival after intrahepatic cholestasis associated with sickle cell disease. J Tenn Med Assoc 1986;79; 199–200.
Shao, SH, Orringer, EP. Sickle cell intrahepatic cholestasis: approach to a difficult problem: two Hb SS patients presenting with fever, leukocytosis, coagulopathy, and extreme hyperbilirubinemia. Am J Gasteroentrol 1995;90;2048–50.
Khurshid, I, Anderson, L, Downie, G, Pape, GS. Sickle cell disease, extreme hyperbilirubinemia, and pericardial tamponade: case report and review of the literature. Crit Care Med 2002;30; 2363–7. Pdf_Folio:132
Tiftik, N, Altintaş, E, Kiykim, A, Uçbilek, E, Sezgin, O. Long-term red blood cell exchange can be used to successfully treat sickle cell intrahepatic cholestasis: a case report. J Clin Apher 2004;19;17–19.
Tsimpoukas, F, Goritsas, C, Kotsanis, A, Aggelis, P, German, V, Ferti, A. Successful outcome of acute sickle cell intrahepatic cholestasis in a patient with sickle/beta+ thalassaemia and chronic hepatitis C virus infection. J Hepatol 2004;40; 1046–7.
Brunetta, DM, Silva-Pinto, AC, do Carmo Favarin de Macedo, M, Bassi, SC, Piccolo Feliciano, J.V. et al. Intrahepatic cholestasis in sickle cell disease: a case report. Anemia 2011; 2011;975731.
Khan, MA, Kerner, JA. Reversal of hepatic and renal failure from sickle cell intrahepatic cholestasis. Dig Dis Sci 2011;56; 1634–6.
Malik, A, Merchant, C, Rao, M, Fiore, RP. Rare but lethal hepatopathy-sickle cell intrahepatic cholestasis and management strategies. Am J Case Rep 2015;16;840.
Author information
Authors and Affiliations
Corresponding author
Additional information
Peer review under responsibility of the International Academy for Clinical Hematology
Data availability statement: The data that support the findings of this study are available from the corresponding author, upon reasonable request. Data resides with first author
Rights and permissions
This is an open access article distributed under the CC BY-NC 4.0 license (https://doi.org/creativecommons.org/licenses/by-nc/4.0/).
About this article
Cite this article
Adkins, B.D., Savani, B.N. & Booth, G.S. Management of Sickle Cell Intrahepatic Cholestasis: An Argument in Favor of Automated Exchange Transfusion. Clin Hematol Int 1, 127–133 (2019). https://doi.org/10.2991/chi.d.190630.001
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2991/chi.d.190630.001